Innoviva, Inc. 13D and 13G filings for Entasis Therapeutics Holdings Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-05-03 5:19 pm Purchase | 2021-05-03 | 13D | Entasis Therapeutics Holdings Inc. ETTX | Innoviva Inc. INVA | 44,807,844 70.600% | 7,462,050 (+19.98%) | Filing |
| 2020-09-01 5:28 pm Purchase | 2020-09-01 | 13D | Entasis Therapeutics Holdings Inc. ETTX | Innoviva Inc. INVA | 37,345,794 69.000% | 34,700,774 (+1311.93%) | Filing |